stella
beta
Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC — Stella
Recruiting
Back to Lung Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
West China Hospital of Sichuan University, Chengdu, Sichuan
View full record on ClinicalTrials.gov